|
||
Original Article |
vβ3 and
vβ5 Integrins, and Protein Kinase C Regulates
vβ5 Binding and Cytoskeletal Linkage
Margaret M. Dyson Vision Research Institute, Box 233, Department of Ophthalmology, Weill Medical College of Cornell University, 1300 York Ave., New York, NY 10021.212-746-8101212-746-2271
sfinne{at}mail.med.cornell.edu
| Abstract |
|---|
|
|
|---|
vβ3 integrin to selectively bind apoptotic cells, initiating their phagocytic removal. In a related process, the retinal pigment epithelium (RPE) employs
vβ5 integrin to recognize spent photoreceptor outer segment particles (OS). Here, we show that apoptotic cells and OS compete for binding to these receptors, indicating that OS and apoptotic cells expose surface signals recognizable by
vβ3 and
vβ5. Particle binding to
vβ5 required protein kinase C (PKC) activation. In RPE,
vβ5 binding was maximally activated even before any phagocytic challenge and was reduced by PKC inhibitors. In macrophages, it was dormant but became activated upon PKC stimulation. PKC-activated
vβ5-mediated binding in macrophages differed from constitutive binding to the same integrin receptor in RPE cells in that the former followed much faster kinetics, similar to particle binding mediated by
vβ3. Activation of
vβ5 for particle binding correlated with its recruitment into a detergent-insoluble fraction, a process sensitive to pharmacological modulation of PKC in both types of phagocytes. Furthermore,
vβ5 but not
vβ3 particle binding required actin microfilaments. These data constitute the first evidence that noninflammatory phagocytes actively regulate the earliest phase of phagocytic clearance, particle binding, by controlling receptor activity.
Key Words: phagocytosis recognition integrins macrophages retinal pigment epithelium
Clearance phagocytosis of apoptotic cells and debris plays a critical role in remodeling and maintenance of tissues. Noninflammatory phagocytosis prevents tissue damage that would result from leakage of cytoplasmic components 12. Typical examples of this macrophage activity are the efficient removal of large numbers of apoptotic cells during embryonic development 3 or of activated granulocytes undergoing programmed cell death at the end of an immune response 4. The binding and phagocytosis phases of apoptotic cell removal each involve specific receptors in the macrophage, such as the lipopolysaccharide receptor CD14 5, phosphatidylserine receptors 6, the integrin receptor
Noninflammatory receptor–mediated clearance of cell debris is also efficiently carried out by a specialized tissue in the retina, the retinal pigment epithelium (RPE).1 RPE cells phagocytose huge loads of material shed by the adjacent photoreceptor layer (
OS binding by RPE cells and apoptotic cell binding by macrophages use the related integrin receptors
The experiments in this report characterize the role of
vβ3 7, and the scavenger receptors SRA1 and CD36 89. Binding receptors recognize phosphatidylserine, oxidized lipids, and other unidentified phagocytic signals exposed by apoptotic cells 1011. The available data suggest that different recognition receptors initiating phagocytosis of apoptotic cells may be used independently, depending on the activation state of the macrophage population 1213. This is especially well established for the availability of
vβ3 integrin for apoptotic cell binding.
vβ3 does not participate in particle binding by macrophages that were previously stimulated by thioglycollate, activated by cytokines, or phagocytically challenged 1214. In contrast,
vβ3 is an important binding receptor in noninflammatory bone marrow– or monocyte-derived macrophages, as
vβ3 function-blocking antibodies or peptides containing the cognate integrin ligand motif Arg-Gly-Asp drastically reduce particle attachment 712. Monocyte-derived macrophages use either
vβ3 integrin or leukocyte-specific integrin receptors
Mβ2 (CD11b/CD18, CR3) and
Xβ2 (CD11c/CD18, CR4), presumably in parallel, to bind apoptotic cells, which have been opsonized with complement components 15. The mechanisms used by macrophages to activate or deactivate specific binding receptors for apoptotic cells are entirely unknown.
7% of their outer segment mass, daily) as part of a circadian renewal program that compensates the damaging effects of light 1617. RPE phagocytosis of shed outer segment particles (OS) is key for the integrity of the eye, as its failure leads to retinal degeneration 1819. RPE cells highly prefer OS over bacteria, yeast, and opsonized red blood cells, even when they may express a population of Fc receptors 20. CD36 is expressed by the RPE and participates in the internalization phase of OS clearance 21. Indirect evidence suggests that a mannose receptor–like activity also plays a role in RPE internalization of OS 22. However, the RPE mannose receptor sequence has not yet been cloned, and its exact role in OS phagocytosis is unclear. Although only some soluble mannose receptor ligands affect OS phagocytosis 2324, yeast and zymosan particles, which are recognized by macrophages via the mannose receptor, do not compete with OS for binding or internalization by RPE cells (20, and our unpublished results).
vβ5 and
vβ3, respectively 2526. However, the binding phases of the two processes show some important differences: (a) RPE cells bind OS slowly (over
2 h) only after a lag phase 2026, whereas macrophages bind particles maximally in 30 min. (b) RPE cells bind OS only at temperatures >17°C 27, whereas a temperature requirement of macrophage binding of apoptotic cells, to our knowledge, has not been reported. However, macrophage binding of particles via Fc receptors or complement receptor β2 integrins is normal at 0°C 28. (c) RPE cells primarily use
vβ5 2526 for particle binding (
vβ5 antibodies reduce binding by 85%), whereas macrophages may use
vβ3 and other receptors, in parallel (
vβ3 antibodies reduce binding by
50%). Very recent work has shown that phagocytosis of apoptotic cells by immature human blood–derived dendritic cells can be reduced to a similar extent by
vβ5 integrin–inhibiting antibodies; upon cytokine-induced maturation, the phagocytic activity of these cells decreases coincident with downregulation of β5 29.
vβ3 and
vβ5 integrin receptors in the initial binding phase of monocyte macrophage and RPE phagocytosis of apoptotic cells and OS. We first tested the hypothesis that the specific particle ligand (OS versus apoptotic cell) could determine the use of a particular integrin,
vβ5 by RPE and
vβ3 by macrophages. The experiments led us to discard this hypothesis as both cell types recognized apoptotic cells and OS efficiently and competitively, employing the same binding integrins they use for their respective physiologic ligands. As both phagocyte types expressed
vβ3 and
vβ5, we tested the hypothesis that the activation of a particular integrin pathway by each cell type could be regulated by specific signaling pathways. Indeed, this was observed: our experiments revealed a critical role for PKC in activating
vβ5 for particle binding. Activation of dormant
vβ5 receptors in macrophages did not alter cell-specific differences in particle binding, as these receptors bound apoptotic cells or OS with fast kinetics distinct from the characteristic slow onset of binding initiating RPE phagocytosis. Both
vβ5 and
vβ3 integrins required temperatures of at least 18°C for particle binding, in contrast to β2 integrins or Fc receptors. Remarkably,
vβ5 receptors themselves became resistant to detergent extraction upon PKC activation. Since intact actin microfilaments were required for
vβ5-mediated particle binding, interaction with the actin cytoskeleton appears to be an important feature of
vβ5 receptor activation.
![]()
Materials and Methods
Top
Abstract
Materials and Methods
Results
Discussion
References
Materials.
Reagents were from Sigma Chemical Co. or GIBCO BRL unless otherwise stated. Pharmacological reagents were obtained from Biomol or Sigma Chemical Co., stored as 1,000x stock solutions in DMSO at –20°C, and diluted into cell culture medium directly before use. The following antibodies were used: rat
vβ3 function-blocking β3 antibody clone F11 3031 and mouse β3 function-blocking antibody clone 2C9.G2 32 were from PharMingen. Immunoprecipitating, function-blocking, heterodimer-selective
vβ5 antibody clone P1F6 33 was from Chemicon. P1F6 recognizes
vβ5 in many species, including rodents (2633; and this study, see Fig. 8). For immunoblot detection, β5 antibodies were purchased from Chemicon or from Upstate Biotechnology (clone B5-IVF2 34), and β3 antibody clone 26 was from Transduction Laboratories. Myeloperoxidase antiserum was from Dako. Mouse
M function-blocking antibody 5C6 35 was a gift from Dr. W.A. Muller (Weill Medical College of Cornell University). Secondary antibodies were from Jackson ImmunoResearch Laboratories.
|
Cell Culture.
J774.A1 murine macrophages, NRK-F49 rat fibroblasts, and rat RPE-J cells were obtained from American Type Culture Collection and routinely maintained in DMEM supplemented with 10 or 4% (RPE) FCS. For binding and phagocytosis experiments, macrophages and fibroblasts were seeded at confluence on glass coverslips for 30 min or overnight before use. RPE-J cells were differentiated on semipermeable filters as described previously 36. Rat primary cells were isolated from adult Long Evans rats (Richard Harlan, Inc.) immediately after CO2 asphyxiation. Rat bone marrow–derived macrophages and rat blood–derived monocyte macrophages were prepared and maintained according to published procedures 1337. In brief, blood-derived monocytes were isolated by plastic adherence after Ficoll gradient purification of leukocytes from anticoagulant-treated rat blood. Bone marrow cells were flushed aseptically from femur bones of Long Evans rats, washed, seeded, and used without repassaging. All primary macrophages were cultured for 6–7 d before use in IMDM, supplemented with 10% autologous serum; bone marrow–derived cell medium was supplemented with 5% L cell–conditioned medium (Sigma Chemical Co.) as a source of M-CSF 13. Primary rat neutrophils, which were isolated from fresh rat blood according to established protocols 38, underwent spontaneous apoptosis over 24 h in culture. HL-60 cells, a gift from Dr. F. Maxfield (Weill Medical College of Cornell University) were maintained in 10% FCS in RPMI. To induce differentiation and apoptosis, HL-60 cells were cultured in the dark at 2 x 105 cells/ml in growth medium containing 1 µM all-trans retinoic acid for 6 d. Before binding or phagocytosis assays, apoptotic cells were routinely tested for viability by trypan blue exclusion and phosphatidylserine surface exposure staining with FITC–annexin V. All populations used were >95% viable and >60% annexin V positive.
Preparation of Photoreceptor OS.
OS were isolated according to established protocols from bovine eyes obtained fresh from the slaughterhouse 39. OS were stored suspended in 10 mM sodium phosphate, pH 7.2, 0.1 M sodium chloride, 2.5% sucrose at –80°C. Before use, OS were thawed and labeled by addition of 20% vol of 1 mg/ml FITC or 0.2 mg/ml Texas red (both from Molecular Probes) in 0.1 M sodium bicarbonate, pH 9.0, for 1 h at room temperature in the dark, before being washed and resuspended in cell culture medium.
Opsonization of Zymosan.
Zymosan particles were opsonized with serum complement components as described previously 40. In brief, 1% zymosan particles in PBS were boiled for 30 min and opsonized in 50% bovine serum in HBSS for 1 h at 37°C. Washed particles were labeled with FITC as described for OS, and stored at 4°C.
Particle Binding and Phagocytosis Experiments.
To study particle binding, phagocytes at confluence were challenged with 10 particles per cell in growth medium (RPE) or serum-free growth medium (other cells) for the duration of the experiment, washed three times with PBS containing 1 mM MgCl2 and 0.2 mM CaCl2 (PBS-CM), and fixed in ice-cold methanol. OS were covalently labeled with FITC or Texas red, and thus could be observed directly. Apoptotic cells were visualized by TUNEL staining or by granulocyte-specific myeloperoxidase immunofluorescence staining using FITC- or Texas red–conjugated secondary antibodies. Nuclei were counterstained with DAPI or propidium iodide at 1 ng/ml in PBS-CM. For competition experiments, OS and apoptotic cells were labeled with different fluorochromes. Particle labeling with either fluorochrome yielded identical results. Unlabeled particles competed with fluorescence-labeled particles for binding and phagocytosis by all cell types. For inhibition experiments, GRGDSP or GRADSP peptides (Calbiochem) were used at 1 mg/ml. Effects of peptides and antibodies were concentration dependent as established previously 26, and maximal effective concentrations of antibodies, 20–50 µg/ml, were used throughout this study. Concentrations of pharmacological reagents were as follows: calphostin C at 100 nM (light activated), cytochalasin D (Cyt D) at 5–20 µM, Gö6976 at 10 nM, hypericin at 5 µM, and latrunculin B at 1 µM. PMA was routinely used at 50 nM; 16–160 nM gave similar results. Cells were pretreated for times indicated in the figure legends with activators or inhibitors before challenge with OS or apoptotic granulocytes in the continuous presence of reagent. Cell viability and morphology remained unchanged, and none of the cell types initiated detectable apoptosis over the course of the experiments. Since experiments were performed on confluent cells, the spreading effect of PMA on macrophages was negligible.
Phagocytosis or binding of OS was quantified by fluorescence scanning of fixed samples as described 26. Samples were scanned with a STORM 860 Imager, at 950 V (blue or red fluorescence setup; Molecular Dynamics). Areas representing the binding by 1–2 x 105 phagocytes were selected, and the fluorescent signals were quantified with ImageQuant 1.2 (Molecular Dynamics). Within one experiment, particle counts directly correlated with particle binding. To compare particle binding of different cell types, as RPE cells and macrophages, the fluorescence of propidium iodide (nuclei, red) and the particle-derived FITC fluorescence were both measured in each field. The binding plus internalization index or the binding index (bound particles at early times of phagocytic challenge) were calculated dividing particle counts by nuclei counts, thereby normalizing for phagocyte numbers. Quenching of fluorescence derived from externally bound particles using trypan blue 2641 allowed determination of the internalization index. Phagocytosis or binding of apoptotic cells was quantified following the same procedure based on TUNEL or myeloperoxidase immunostaining fluorescence emissions; binding indices were determined dividing by nuclei counts of control fields, so as not to count apoptotic nuclei. Microscopic observation revealed that 75% of RPE-J cells and >90% of J774 cells had bound or phagocytosed an average of 5 ± 1 OS after 2 h. Using the double fluorescence scanning method on the same samples, this translated into a mean index combining binding plus internalization of 7.6 ± 0.9 for macrophages and 6.3 ± 0.9 for RPE. After 30 min, 75% of macrophages had bound multiple OS; this translated to a mean binding index of 3.8 ± 0.4. At this time point, <20% of particles had been internalized by macrophages, similar to the 2-h time point of RPE 2641.
Immunofluorescence Microscopy.
Samples were fixed in ice-cold methanol or 4% paraformaldehyde in PBS-CM and processed as described previously 42. Samples were observed with a Nikon fluorescence microscope E600. Digital images were acquired with a back-illuminated cooled CCD camera (CCD1000 PB; Princeton Instruments), translated using MetaMorph (Universal Imaging), and recompiled in Adobe Photoshop® 4.0. Horizontal (x–y) sections were acquired at 0.5-µm steps using a z motor (Prior), and out of focus light was removed using MetaMorph.
Cell Fractionation.
Integrin cytoskeletal association was assayed by cell fractionation into detergent-soluble and insoluble fractions according to previously described protocols 43. Confluent cells in 6-cm dishes, preincubated with pharmacological reagents or vehicle as before binding or phagocytosis assays, were extracted in 800 µl 50 mM MES, 5 mM MgCl2, 3 mM EGTA, 0.5% Triton X-100, pH 6.4, for 40 s at room temperature (soluble fraction). The remaining cellular material was completely solubilized in an equal volume of RIPA (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 2 mM CaCl2, 1 mM MgCl2, 0.1% SDS, 1% sodium desoxicholate, 1% Triton X-100) (insoluble fraction). Equal volumes of soluble and insoluble fractions were compared by 7.5% SDS-PAGE and immunoblotting. For immunoprecipitation of integrins from the different fractions, the soluble fraction was harvested as described above, whereas the insoluble fraction was obtained by scraping the remaining cellular material in an equal volume of 50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 2 mM CaCl2, 1 mM MgCl2, 1% Triton X-100, 1% NP-40 supplemented with 2 mM each of aprotinin, leupeptin, pepstatin, iodoacetamide, and PMSF, and 1 mM N-ethylmaleimide (IP lysis buffer), vortexing for 30 min at 4°C. This procedure completely solubilized integrin proteins. Immunoprecipitations were performed from this insoluble and the soluble fraction as follows.
Surface Protein and Immunoprecipitations, SDS-PAGE, and Immunoblotting.
For metabolic labeling, confluent cells on plastic dishes were starved for 90 min in cysteine, methionine-free DMEM, and labeled with 0.1 mCi/ml 35S Express (NEN) for 12–14 h. Preincubation with pharmacological reagents or vehicle as control was performed as before binding/phagocytosis assays. To biotinylate surface proteins, cells were incubated with Sulfo-NHS-LC biotin (Pierce Chemical Co.) at 0.5 mg/ml in PBS-CM twice for 20 min on ice. Excess reactive biotin was quenched in 50 mM NH4Cl in PBS-CM. Cells were lysed in IP lysis buffer for 30 min. Protein concentration of supernatant lysates was determined according to Bradford 44. Crude lysates were analyzed by nonreducing 7.5% SDS-PAGE followed by Western blot detection of integrins as published previously 45. Streptavidin-agarose precipitation has been described in detail elsewhere 46. Immunoprecipitates were formed incubating precleared lysate with 5 µg P1F6 IgG or nonimmune mouse IgG, with 5 µg rabbit anti–mouse IgG, and with 5 mg protein A–sepharose, each for 1 h at 4°C. Samples were washed four times in 50 mM Tris-HCl, pH 8.5, 0.5 M NaCl, 2 mM CaCl2, 1 mM MgCl2, 1 mg/ml egg albumin, 0.1% Triton X-100 eluted in nonreducing or reducing SDS sample buffer, and analyzed on 10% SDS-PAGE followed by fluorography or blotting. Blots were incubated with integrin antibodies, horseradish peroxidase–conjugated streptavidin, or secondary antibodies, followed by ECL (NEN) detection. X-ray films were scanned, and signals were quantified using NIH Image 1.61.
| Results |
|---|
|
|
|---|
vβ3 integrin receptors to bind apoptotic cells before phagocytosis 7, whereas RPE cells bind OS via
vβ5 integrins 2526. We initially tested the hypothesis that the characteristic choice of different integrin receptors by macrophages and RPE cells was determined by differences in the bound particles. To this end, we exposed the phagocytes to the physiologic ligands of the other cell, i.e., macrophages to OS and RPE cells to apoptotic cells (Fig. 1). Rat bone marrow macrophages and the murine macrophage cell line J774, which retains the
vβ3 integrin–dependent apoptotic cell clearance mechanism of noninflammatory monocyte macrophages 13, efficiently bound and phagocytosed OS (Fig. 1, a and b). Primary cultures of rat RPE, and rat (RPE-J) and human (ARPE-19) RPE cell lines identified and took up apoptotic granulocytes (and other apoptotic cells; data not shown), but not their nonapoptotic counterparts (Fig. 1c–f). Most subsequent studies were performed on J774 macrophages and RPE-J cells, but were confirmed on rat bone marrow–derived macrophages and primary rat RPE cultures.
|
|
vβ5 antibody P1F6 only blocked RPE recognition (Fig. 2 b). OS and apoptotic cells competed for binding by both macrophages and RPE cells (Fig. 2 c). These experiments indicate that neither macrophage nor RPE binding receptor systems discriminate between ligands of both particles and that these systems involve
vβ3 in macrophages and
vβ5 in RPE cells.
Binding of Apoptotic Cells and OS by
vβ5 Is Dormant in Macrophages but May Be Activated by PKC.
We tested three hypotheses that might account for particle binding by different integrin binding receptors in macrophages and RPE cells. Hypothesis 1 was that cell type–specific integrin protein expression determined receptor availability for particle binding. However, Fig. 3 shows that selective integrin expression was not involved, as both β3 and β5 were expressed at similar levels by J774 cells, rat bone marrow–derived macrophages, and RPE-J cells. Immunoprecipitation of
vβ5 from RPE and macrophage lysate using the antibody P1F6, which recognizes only intact heterodimers, and coimmunoprecipitation of β3 integrin with
v integrin confirmed the formation of
vβ3 (data not shown) and
vβ5 receptors (see Fig. 8). We have shown previously that the steady state distribution of β3 integrins is basolateral in the RPE 26. Although this does not exclude a temporary presence of
vβ3 at the apical phagocytic surface, this spatial segregation may render it less available for efficient apoptotic cell or OS binding by the RPE than
vβ5, which localizes apically and cytoplasmically. In contrast, double immunofluorescence staining with antibodies recognizing the β3 extracellular domain and with P1F6 antibodies specific for the extracellular face of the
vβ5 receptor complex showed that in nonpermeabilized macrophages, both antigens were localized in the same optical sections of the plasma membrane of a given cell, even if their distribution within the plane of the membrane differed. Like β3 integrins,
vβ5 receptors localized partially to basal attachment sites of macrophages but were also available at their free surface for binding to apoptotic cells or OS.
|
vβ3 for apoptotic cell or OS binding might be based on the faster early kinetics of this pathway over
vβ5-mediated uptake (Fig. 2 a). To facilitate detection of a hidden
vβ5 particle binding activity,
vβ3 receptors were depleted from the free macrophage surface. When compared with control cells plated on laminin (which is not a substrate for either
vβ3 or
vβ5), a large fraction of
vβ3 receptors was recruited to the attached surface in macrophages plated on the specific
vβ3 substrate fibrinogen (47; compare Fig. 4, a1 and a2, with Fig. 4, b1 and b2), resulting in a reduction in particle binding of 40% after 30 min of particle challenge (Fig. 5 a), and a 44% decrease of combined binding and internalization even after 90 min (Fig. 5 b).
vβ5 receptor distribution remained unchanged on fibrinogen, as judged from the similar appearance of
vβ5 immunofluorescence signals on both attached and open cell surfaces on laminin and fibrinogen (compare Fig. 4, a3 and a4, with Fig. 4, b3 and b4). However, the remaining binding at 30 min and the combined binding plus internalization at 90 min were still reduced by β3 but not by
vβ5 function-blocking antibodies (Fig. 5). Incubation with β3 antibody in the presence of the peptide inhibitor GRGDSP did not have an additive effect (but the peptide alone reduced binding by
30%; data not shown, and see Fig. 2 b), indicating that
vβ3 was the only RGD-sensitive receptor, which mediates apoptotic cell or OS recognition in this system. However, ligand binding by leukocyte β2 integrins may not be inhibitable by RGD peptides 48. At the 90-min time point, at least 65% of the particles had been internalized (Fig. 5 b, black bars). Comparing total and internal particles of laminin- and fibrinogen-seeded macrophages, differences in internalized particles were less pronounced than differences in surface-bound particles (as deduced by subtracting internal from total particles), confirming that attachment to fibrinogen inhibited particle binding but not internalization (Fig. 5 b, gray and black bars). Similar results were obtained when cells were plated on β3 integrin antibodies or on vitronectin, a substrate for both
vβ3 and
vβ5 (Fig. 5). These experiments indicate that
vβ5 integrin receptors are present in macrophages but are not active in apoptotic cell or OS binding.
|
|
vβ3 integrin,
vβ5 is sensitive to pharmacological modulation by protein kinase C (PKC) 334950. Here, we compared the effects on macrophage and RPE particle binding of generic PKC activation using phorbol esters (PMA), and inhibition by calphostin C, Gö6976, and hypericin. Inhibitors were used at concentrations near IC50 for PKC. PMA treatment did not alter RPE particle binding; on the other hand, calphostin C, Gö6976, and hypericin reduced binding by RPE cells (Fig. 6 a). Significant inhibition (by 54%) by calphostin C required a preincubation of 3 h. It is possible that RPE cells take up calphostin C more slowly than other cultured cells or maintain lower cytoplasmic concentrations of this inhibitor. Hypericin and Gö6976 significantly reduced particle binding after as little as 30 min of preincubation by 39 and 22%, respectively, but both were also more effective after 3 h of preincubation (69 and 81% reduction). These experiments indicate that the apoptotic cell or OS binding activity of resting confluent RPE cells is drastically reduced by pharmacological inhibition of PKC.
|
vβ5 antibody Fab fragments (Fig. 6 b). Thus, PMA treatment activated
vβ5-mediated particle binding that was dormant in untreated macrophages. The effect of the PMA treatment directly involved PKC, since it was abolished by preincubation of cells with calphostin C for 20 min before PMA and particle challenge. To confirm the PKC dependence of
vβ5-mediated apoptotic cell or OS binding in a different cell context, we carried out similar experiments in NRK-F49 fibroblasts. When challenged with OS for 2 h, these cells bind (but do not internalize) few OS, equivalent to one fifth of the number bound by RPE over the same period (Fig. 2 a), although they express comparable levels of
v, β3, and β5 integrins (Fig. 3). Incubation with integrin antibodies had no effect on the basal NRK-F49 particle binding of apoptotic cells or OS (data not shown). However, addition of PMA stimulated particle binding by NRK-F49 fibroblasts by 250% to a binding index of 3.4 ± 0.5, which is an increase to approximately half-maximal binding capacity of professional phagocytes. Strikingly, this induced binding activity was completely sensitive to RGD peptides, was blocked specifically by
vβ5 antibodies, and was not sensitive to β3 antibodies (Fig. 6 c). Over the 2-h time period studied, NRK-F49 fibroblasts retained particles at the surface and did not internalize them, regardless of pharmacological stimulation. These experiments demonstrate that inhibition and activation of PKC regulate the function of
vβ5 integrin as binding receptor for apoptotic cells or OS.
To determine if the stimulated
vβ5 integrin–mediated particle binding in macrophages exhibited typical features of OS binding by RPE cells, we compared the temperature sensitivity and kinetics of particle binding and internalization by J774 cells, in the presence or absence of PMA. Total (bound plus internalized) and internalized particles were measured to calculate binding and internalization indices plotted in Fig. 7. Onset of binding of apoptotic cells or OS to control and PMA-stimulated cells occurred with the same rapid kinetics typical of macrophages (Fig. 7 a, solid lines). When challenged with particles for 30 min or longer, both control and PMA-stimulated cells increasingly internalized bound material (Fig. 7 a, dotted lines), resulting in a decrease in particles detected bound to the cell surface. J774 cells, which were equilibrated to 18°C before particle challenge, also bound both particles with the same fast kinetics regardless of whether they had been preincubated with PMA or with solvent alone, albeit slightly delayed regarding the 37°C time course (Fig. 7 b, solid lines). Under these conditions, <10% of total particles were internalized regardless of PMA treatment and time of incubation (Fig. 7 b, dotted lines). Finally, incubation at 14°C or on ice during particle challenge abolished particle binding with or without PMA treatment (Fig. 7c and Fig. d), while allowing normal binding of complement-opsonized zymosan via macrophage
Mβ2, sensitive to
M-blocking antibody 5C6 (data not shown). These experiments demonstrate that apoptotic cell or OS binding by macrophages via
vβ3 or
vβ3 plus
vβ5 integrin shows the same temperature requirement as particle binding via
vβ5 to RPE cells. On the other hand, PMA-stimulated macrophages, which possess an activated
vβ5 integrin, bind apoptotic cells or OS with the same rapid kinetics as control macrophages, which do not use
vβ5, indicating that RPE particle binding does not occur slowly due to an intrinsic property of
vβ5.
|
vβ5 Is Linked to the Actin Cytoskeleton.
vβ5-mediated binding of apoptotic cells or OS by PKC, we searched for biochemical changes associated with PKC activation. Pharmacological activation or inhibition of PKC did not influence
vβ5 receptor levels in either cell type (Fig. 8 a, compare lane 2 with lane 3, and lane 5 with lane 6) or their steady state expression levels at the cell surface, as revealed by surface biotinylation,
vβ5 immunoprecipitation, and streptavidin blot (Fig. 8 b, lanes 1–6) or enrichment of plasma membrane fractions and β5 immunoblot (Fig. 8 b, lanes 7–12). Incomplete extraction of plasma membrane proteins with 0.5% Triton X-100 in a buffer that preserves the cortical cytoskeleton serves to distinguish integrin receptors, which are stabilized by actin cytoskeletal elements 4351. PKC inhibition in RPE and PKC activation in macrophages correlated with decreased and increased β5 resistance to nonionic detergent, respectively, as shown in Fig. 9, a and b, suggesting a regulation of β5 association with actin cytoskeletal elements. β5 was 65% insoluble in control RPE, 58% insoluble in PMA-treated RPE, but only 33% insoluble in RPE treated with PKC inhibitor Gö6976. In contrast, β5 was mostly soluble in control macrophages (5% insoluble) but became 78% insoluble after PMA incubation. This effect was greatly inhibited in the presence of Gö6976 (23% insoluble). This effect was specific for β5, as β3 solubility was unaffected by PKC activation/inhibition (Fig. 9, a and b, lower lanes). β3 integrin was 30% insoluble in RPE and 40% insoluble in J774 cells, regardless of treatment. Pretreatment of RPE or macrophages with the actin microfilament disrupting drug, Cyt D, rendered β3 and β5 completely soluble in RPE and macrophages, confirming that integrin resistance to nonionic detergent extraction in our biochemical analysis reflected their association with actin microfilaments (Fig. 9, a and b, lanes 7 and 8). As expected, PMA treatment did not induce integrin insolubility in cells in which actin microfilaments had been disrupted by Cyt D (Fig. 9, a and b, lanes 9 and 10). We further determined the detergent solubility of intact
vβ5 receptors (Fig. 9 c). Strikingly, the effect of PKC activation or inhibition on
vβ5 heterodimer solubility was most pronounced: 90% of
vβ5 in RPE cells was insoluble but became mostly solubilized (26% insoluble) upon incubation with the PKC inhibitor Gö6976 (Fig. 9 c, lanes 1–6). In control macrophages, the entire
vβ5 receptor pool was present in the soluble fraction (Fig. 9 c, lanes 8 and 10). In contrast, PMA-treated macrophages exhibited 62% insoluble
vβ5 (Fig. 9 c, lanes 11 and 12). Attempts to visualize the change in receptor solubility by indirect immunofluorescence staining of
vβ5 or β5 in cells fixed before or after a short pulse of nonionic detergent failed, as, unfortunately, detergent pretreatment abolished all immunoreactivity. Loss of immunoreactivity after detergent treatment was independent of cell type or pharmacological treatment, suggesting that antibody–antigen binding did not tolerate detergent treatment followed by paraformaldehyde fixation. Nonetheless, the biochemical changes observed clearly demonstrate that
vβ5 function as particle binding receptor correlates with its increased resistance to nonionic detergent extraction, which was reversibly regulated by PKC signaling.
|
vβ5-mediated particle binding, we challenged J774 macrophages with OS in the presence or absence of PMA and Cyt D. Fig. 10 shows particle binding determined at 18°C to minimize phagocytosis of bound particles. OS bound efficiently to control macrophages even in the presence of Cyt D (Fig. 10), in both cases in an β3 integrin–sensitive,
vβ5-independent manner (average β3 antibody inhibition 59% in control cells, 42% in Cyt D–treated cells). Increased OS binding in the presence of PMA exhibited the dual β3- and
vβ5-dependent mechanism (51% inhibited by β3 antibody, 39% inhibited by
vβ5 antibody), and blocking of both integrins with a combination of antibodies resulted in maximal inhibition of OS binding (75%). Strikingly, the addition of Cyt D decreased OS binding to PMA-treated cells by 40%, abolishing the increase induced by PMA. Addition of
vβ5-inhibiting antibody to these cells had no effect, whereas OS binding remained sensitive to β3-inhibiting antibodies (52% inhibition). Similar effects on PMA-induced particle binding only were observed when 1 µM latrunculin B, a different actin-disruptive drug, was substituted for Cyt D (data not shown). When we tested RPE-J particle binding in the presence of 5–20 µM Cyt D, we also found their binding activity reduced. However, the morphology of the epithelium was dramatically altered after 2 h of actin disruption. These experiments demonstrate that, in macrophages and RPE-J cells, binding of apoptotic cells or OS to
vβ5 integrin receptors but not to
vβ3 required intact actin microfilaments.
|
| Discussion |
|---|
|
|
|---|
vβ3 and
vβ5. Several important aspects of the particle recognition functions of these integrins were unraveled.
Recognition Mechanisms of RPE Cells and Monocyte Macrophages Do Not Distinguish between Surface Signals of Photoreceptor Outer Segments and Signals Exposed during Apoptosis.
Although RPE cells lack inflammatory phagocytic mechanisms mediated in immune cells by Fc receptors, complement receptors, and glycan receptors, they possess a highly efficient clearance pathway for OS. The RPE phagocytic mechanism for OS and apoptotic cells has a capacity similar to the monocyte macrophage phagocytic mechanism. Our results confirm and extend earlier reports that described the extraordinary specificity of the RPE recognition machinery towards OS 20 and of the machinery used by noninflammatory macrophages for apoptotic over normal cells 4.OS and apoptotic cells quantitatively compete for both monocyte macrophage and RPE binding, demonstrating that the binding receptors used by either cell type to initiate phagocytosis of these types of particles do not discriminate between them. They also suggest that at least some of the local surface changes elicited by the daily photoreceptor outer segment renewal program are functionally equivalent to the recognition signals exposed during apoptosis.
RPE Cells Use
vβ5 Integrin, Whereas Macrophages Use
vβ3 Integrin to Bind Both OS and Apoptotic Cells.
Surprisingly, rat primary and murine J774 macrophages used
vβ3 integrin to bind OS, even though they expressed abundant
vβ5 integrin at the cell surface. The partial reduction in particle binding observed when using
vβ3 inhibitory antibodies and RGD peptides on macrophages confirms earlier reports that they also use nonintegrin binding receptors for apoptotic cells or OS, presumably in parallel mechanisms (for a review, see reference 11). In contrast, RPE cells likely use
vβ5 integrin as primary binding receptor for OS, as
vβ5-inhibiting antibodies abolish 85% of particle binding. RPE cells bound apoptotic cells as efficiently as OS via an
vβ5-dependent pathway, even though they express equal levels of β3 integrins as macrophages. Since β3 integrins in RPE cells are polarized at the basolateral surface of the RPE, their availability for particle binding may be limited. Although we expect this hypothesis to be difficult to test experimentally in epithelial cells, macrophages do not share similar permeability barriers between plasma membrane domains. Indeed, on appropriate immobilized substrates or specific antibodies, β3 integrins were efficiently trapped at macrophage attachment sites, leaving
vβ5 receptors exposed at the particle contact surface of the phagocytes. In spite of their favorable exposure,
vβ5 receptors failed to mediate apoptotic cell or OS binding. These experiments clearly demonstrate that neither the ligand (OS versus apoptotic cells), the exclusive expression of a given integrin receptor (
vβ3 versus
vβ5), nor its localization at the site of particle contact is sufficient to generate the characteristic receptor selectivity of RPE and macrophage particle recognition.
The Selection of a Particular Integrin Receptor by a Given Phagocyte Is Determined by the Activation of Specific Signaling Pathways.
Our results show that specific cellular context determines which integrin receptor,
vβ3 or
vβ5, will be activated for recognition and binding of OS and apoptotic cells. Pharmacological studies revealed that the PKC signaling pathway plays a key role in the activation of
vβ5 for particle binding. Interestingly, RPE cells possess a maximally activated
vβ5 integrin–gated binding mechanism that can be blocked by PKC inhibitors but cannot be enhanced by PKC stimulators. In contrast, monocyte macrophages constitutively express a functionally equivalent binding mechanism insensitive to PKC, in which
vβ3 plays an important role, but activate a dormant
vβ5 binding mechanism upon PKC stimulation that acts in parallel with their
vβ3 pathway. Although there is no evidence to date supporting a functional role for the novel
vβ5-mediated particle recognition mechanism in phagocytosis by monocyte macrophages, it is likely that this route may be important in vivo. Indeed, an active
vβ5-dependent phagocytic recognition mechanism for apoptotic cells was recently described in immature dendritic cells 29, and our results predict that PKC signaling may also be involved in the regulation of
vβ5 binding activity in these cells. Future studies should address the molecular mechanisms underlying
vβ5 integrin activation by cellular inside-out signaling mechanisms involving PKC (for a recent review, see reference 52). It is equally important to understand the unavailability of the abundant
vβ3 integrin receptors in the RPE, which, as mentioned above, may be related to their subcellular distribution, and the
vβ3 activation in macrophages.
Temperature Sensitivity (18°C) May Be an Intrinsic Property of Recognition Receptors for Apoptotic Cells and OS, Whereas the Kinetics and the Restoration of
v Integrin–mediated Particle Binding Are Determined by Cellular Context.
Particle binding involving both
vβ3 and
vβ5 integrins share a requirement of temperatures of at least 18°C, which may be a characteristic property of receptor mechanisms recognizing apoptotic cells and OS. Importantly, our results show that the activation of
vβ5-mediated particle recognition in macrophages by PKC did not result in slower binding or a lag phase after particle challenge, as would have been expected from the very slow kinetics of this process in RPE cells. Furthermore, RPE cells retain their
vβ5 integrin–dependent activity even after successive phagocytic challenges in vivo, and in vitro (Finnemann, S.C., unpublished data). In contrast, macrophages lose their
vβ3 integrin–dependent phagocytic recognition mechanism upon an initial particle challenge 2. Thus, RPE cells are permanent noninflammatory phagocytes whose clearance mechanism exhibits unique binding characteristics that cannot solely be attributed to intrinsic properties of their primary recognition receptor,
vβ5 integrin.
PKC Activation or Inhibition Controls
vβ5 Integrin Function as Binding Receptor for Apoptotic Cells or OS by Regulating Its Interaction with Cytoskeletal Elements:
vβ5 but Not
vβ3 Integrin–mediated Particle Binding Requires Intact Actin Microfilaments.
Our findings agree well with earlier investigations which demonstrated that
vβ5 but not
vβ3 integrin function is sensitive to modulation by PKC signaling 33495053. However, this is the first report to demonstrate a specific effect of PKC on the association of
vβ5 itself with the actin cytoskeleton. Our biochemical assays did not determine whether PKC induced a direct or indirect association of
vβ5 with actin. Lewis et al. 50 have shown a correlation between PMA activation of
vβ5 and a redistribution or activation of several cytoskeleton-associated molecules, e.g.,
-actinin, tensin, and vinculin. These actin-associated proteins may mediate both mechanical as well as signaling roles of integrin receptors. Cytoskeleton-associated proteins and their roles in apoptotic cell or OS binding and subsequent noninflammatory phagocytosis have yet to be studied in detail. Before inflammatory phagocytosis, particle binding to surface Fc receptors or
Mβ2 integrins appears to be independent of the integrity of the actin cytoskeleton 5455. The hypothesis that binding of the same particle to a different integrin binding receptor, in response to phagocyte- rather than ligand-specified signals, induces different outside-in signaling effects, which ultimately determines properties of later phases of phagocytic clearance, is intriguing and will be the subject of further studies. The unique susceptibility of RPE phagocytes to genetic manipulation by viral or plasmid expression vectors in vitro and in vivo 4256 will certainly be helpful in future studies designed to characterize the roles of specific actin binding and regulatory proteins in apoptotic cell or OS binding and phagocytosis.
| Acknowledgments |
|---|
This work was supported by National Institutes of Health grant EY08538 and a Jules and Doris Stein Professorship awarded by the Research to Prevent Blindness Foundation to E. Rodriguez-Boulan. S.C. Finnemann was supported by a David Warfield Fellowship in Ophthalmology of The New York Community Trust and The New York Academy of Medicine, and a Norman and Rosita Winston Foundation Fellowship in Biomedical Research.
Submitted: 7 May 1999
Revised: 21 July 1999
Accepted: 26 July 1999
| References |
|---|
|
|
|---|
Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R. & Girkontaite I.. Immunosuppressive effects of apoptotic cells, Nature., 390, 1997, 350–351.[Medline]
Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y. & Henson P.M.. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF, J. Clin. Invest., 101, 1998, 890–898.[Medline]
Jacobson M.D., Weil M. & Raff M.C.. Programmed cell death in animal development, Cell., 88, 1997, 347–354.[Medline]
Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M. & Haslett C.. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages, J. Clin. Invest., 83, 1989, 865–875.[Medline]
Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L. & Gregory C.D.. Human CD14 mediates recognition and phagocytosis of apoptotic cells, Nature., 392, 1998, 505–509.[Medline]
Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L. & Henson P.M.. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages, J. Immunol., 148, 1992, 2207–2216.[Abstract]
Savill J., Dransfield I., Hogg N. & Haslett C.. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis, Nature., 343, 1990, 170–173.[Medline]
Platt N., Suzuki H., Kurihara Y., Kodama T. & Gordon S.. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro, Proc. Natl. Acad. Sci. USA., 93, 1996, 12456–12460.
Savill J., Hogg N., Ren Y. & Haslett C.. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis, J. Clin. Invest., 90, 1992, 1513–1522.[Medline]
Savill J.. Apoptosis. Phagocytic docking without shocking, Nature., 392, 1998, 442–443.[Medline]
Platt N., da Silva R.P. & Gordon S.. Recognizing deaththe phagocytosis of apoptotic cells, Trends Cell Biol., 8, 1998, 365–372.[Medline]
Fadok V.A., Savill J.S., Haslett C., Bratton D.L., Doherty D.E., Campbell P.A. & Henson P.M.. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells, J. Immunol., 149, 1992, 4029–4035.[Abstract]
Pradhan D., Krahling S., Williamson P. & Schlegel R.A.. Multiple systems for recognition of apoptotic lymphocytes by macrophages, Mol. Biol. Cell., 8, 1997, 767–778.[Abstract]
Fadok V.A., Laszlo D.J., Noble P.W., Weinstein L., Riches D.W. & Henson P.M.. Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells, J. Immunol., 151, 1993, 4274–4285.[Abstract]
Mevorach D., Mascarenhas J.O., Gershov D. & Elkon K.B.. Complement-dependent clearance of apoptotic cells by human macrophages, J. Exp. Med., 188, 1998, 2313–2320.
Young R.W. & Bok D.. Participation of the retinal pigment epithelium in the rod outer segment renewal process, J. Cell Biol., 42, 1969, 392–403.
Young R.W.. The renewal of photoreceptor cell outer segments, J. Cell Biol., 33, 1967, 61–72.
Bok D. & Hall M.O.. The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat, J. Cell Biol., 49, 1971, 664–682.
Edwards R.B. & Szamier R.B.. Defective phagocytosis of isolated rod outer segments by RCS rat retinal pigment epithelium in culture, Science., 197, 1977, 1001–1003.
Mayerson P.L. & Hall M.O.. Rat retinal pigment epithelial cells show specificity of phagocytosis in vitro, J. Cell Biol., 103, 1986, 299–308.
Ryeom S.W., Sparrow J.R. & Silverstein R.L.. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium, J. Cell Sci., 109, 1996, 387–395.[Abstract]
Boyle D., Tien L.F., Cooper N.G., Shepherd V. & McLaughlin B.J.. A mannose receptor is involved in retinal phagocytosis, Invest. Ophthalmol. Vis. Sci., 32, 1991, 1464–1470.
Hall M.O. & Abrams T.A.. The phagocytosis of ROS by RPE cells is not inhibited by mannose-containing ligands, Exp. Eye Res., 53, 1991, 167–170.[Medline]
Lutz D.A., Guo Y. & McLaughlin B.J.. Natural, high-mannose glycoproteins inhibit ROS binding and ingestion by RPE cell cultures, Exp. Eye Res., 61, 1995, 487–493.[Medline]
Miceli M.V., Newsome D.A. & Tate D.J.. Vitronectin is responsible for serum-stimulated uptake of rod outer segments by cultured retinal pigment epithelial cells, Invest. Ophthalmol. Vis. Sci., 38, 1997, 1588–1597.
Finnemann S.C., Bonilha V.L., Marmorstein A.D. & Rodriguez-Boulan E.. Phagocytosis of rod outer segments by retinal pigment epithelial cells requires
vβ5 integrin for binding but not for internalization, Proc. Natl. Acad. Sci. USA., 94, 1997, 12932–12937.
Hall M.O. & Abrams T.. Kinetic studies of rod outer segment binding and ingestion by cultured rat RPE cells, Exp. Eye Res., 45, 1987, 907–922.[Medline]
Griffin F.M. Jr., Griffin J.A., Leider J.E. & Silverstein S.C.. Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane, J. Exp. Med., 142, 1975, 1263–1282.
Albert M.L., Pearce S.F.A., Francisco L.M., Sauter B., Roy P., Silverstein R.L. & Bhardwaj N.. Immature dendritic cells phagocytose apoptotic cells via
vβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes, J. Exp. Med., 188, 1998, 1359–1368.
Helfrich M.H., Nesbitt S.A. & Horton M.A.. Integrins on rat osteoclastscharacterization of two monoclonal antibodies (F4 and F11) to rat β3, J. Bone Miner. Res., 7, 1992, 345–351.[Medline]
Crippes B.A., Engleman V.W., Settle S.L., Delarco J., Ornberg R.L., Helfrich M.H., Horton M.A. & Nickols G.A.. Antibody to β3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat, Endocrinology., 137, 1996, 918–924.[Abstract]
Schultz J.F. & Armant D.R.. β1- and β3-class integrins mediate fibronectin binding activity at the surface of developing mouse peri-implantation blastocysts. Regulation by ligand-induced mobilization of stored receptor, J. Biol. Chem., 270, 1995, 11522–11531.
Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A. & Cheresh D.A.. Definition of two angiogenic pathways by distinct
v integrins, Science., 270, 1995, 1500–1502.
Pasqualini R., Bodorova J., Ye S. & Hemler M.E.. A study of the structure, function and distribution of β5 integrins using novel anti-β5 monoclonal antibodies, J. Cell Sci., 105, 1993, 101–111.[Abstract]
Rosen H. & Gordon S.. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo, J. Exp. Med., 166, 1987, 1685–1701.
Nabi I.R., Mathews A.P., Cohen-Gould L., Gundersen D. & Rodriguez-Boulan E.. Immortalization of polarized rat retinal pigment epithelium, J. Cell Sci., 104, 1993, 37–49.[Abstract]
Musson R.A.. Human serum induces maturation of human monocytes in vitro, Am. J. Pathol., 111, 1983, 331–340.[Abstract]
Savill J.S., Henson P.M. & Haslett C.. Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge-sensitive" recognition mechanism, J. Clin. Invest., 84, 1989, 1518–1527.[Medline]
Molday R.S., Hicks D. & Molday L.. Peripherin. A rim-specific membrane protein of rod outer segment discs, Invest. Ophthalmol. Vis. Sci., 28, 1987, 50–61.
Murata T., Sullivan J.A., Sawyer D.W. & Mandell G.L.. Influence of type and opsonization of ingested particle on intracellular free calcium distribution and superoxide production by human neutrophils, Infect. Immun., 55, 1987, 1784–1791.
Hed J.. Methods for distinguishing ingested from adherent particles, Methods Enzymol., 132, 1986, 198–204.[Medline]
Marmorstein A.D., Gan Y.C., Bonilha V.L., Finnemann S.C., Csaky K.G. & Rodriguez-Boulan E.. Apical polarity of N-CAM and EMMPRIN in retinal pigment epithelium resulting from suppression of basolateral signal recognition, J. Cell Biol., 142, 1998, 697–710.
Fey E.G., Wan K.M. & Penman S.. Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffoldthree-dimensional organization and protein composition, J. Cell Biol., 98, 1984, 1973–1984.
Bradford M.M.. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 1976, 248–254.[Medline]
Finnemann S., Kühl M., Otto G. & Wedlich D.. Cadherin transfection of Xenopus XTC cells downregulates expression of substrate adhesion molecules, Mol. Cell. Biol., 15, 1995, 5082–5091.[Abstract]
Marmorstein A.D., Zurzolo C., Le Bivic A. & Rodriguez-Boulan E.. Cell surface biotinylation techniques and determination of protein polarity, Celis J.E.. Cell BiologyA Laboratory Handbook, Vol. 4, 1998, 341–350, Academic Press, Inc., New York.
Smith J.W., Vestal D.J., Irwin S.V., Burke T.A. & Cheresh D.A.. Purification and functional characterization of integrin
vβ5. An adhesion receptor for vitronectin, J. Biol. Chem., 265, 1990, 11008–11013.
Arnaout M.A.. Structure and function of the leukocyte adhesion molecules CD11/CD18, Blood., 75, 1990, 1037–1050.
Klemke R.L., Yebra M., Bayna E.M. & Cheresh D.A.. Receptor tyrosine kinase signaling required for integrin
vβ5-directed cell motility but not adhesion on vitronectin, J. Cell Biol., 127, 1994, 859–866.
Lewis J.M., Cheresh D.A. & Schwartz M.A.. Protein kinase C regulates
vβ5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation, J. Cell Biol., 134, 1996, 1323–1332.
Shaw L.M., Messier J.M. & Mercurio A.M.. The activation dependent adhesion of macrophages to laminin involves cytoskeletal anchoring and phosphorylation of the
6β1 integrin, J. Cell Biol., 110, 1990, 2167–2174.
Hughes P.E. & Pfaff M.. Integrin affinity modulation, Trends Cell Biol., 8, 1998, 359–364.[Medline]
Brooks P.C., Klemke R.L., Schon S., Lewis J.M., Schwartz M.A. & Cheresh D.A.. Insulin-like growth factor receptor cooperates with integrin
vβ5 to promote tumor cell dissemination in vivo, J. Clin. Invest., 99, 1997, 1390–1398.[Medline]
Newman S.L., Mikus L.K. & Tucci M.A.. Differential requirements for cellular cytoskeleton in human macrophage complement receptor- and Fc receptor-mediated phagocytosis, J. Immunol., 146, 1991, 967–974.[Abstract]
Allen L.A. & Aderem A.. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor–mediated phagocytosis in macrophages, J. Exp. Med., 184, 1996, 627–637.
Li T. & Davidson B.L.. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer, Proc. Natl. Acad. Sci. USA., 92, 1995, 7700–7704.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|